Literature DB >> 34637098

Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review.

Mateus de Almeida Rainho1, Andre Luiz Mencalha2, Alessandra Alves Thole3.   

Abstract

Colorectal cancer (CRC) is ranked third most incident and second most deadly around the world, and even though treatments significantly developed over the years, overall survival remains low. This scenario has the contribution of cancer stem cells (CSC), a subpopulation of the heterogeneous tumor bulk, considered to be responsible for the tumor maintenance, conventional therapies resistance, metastasis, and recurrence. In this regard, hypoxia appears as an important component of tumor microenvironment and CSC niche, being associated with a worse prognosis. Therefore, it is vital the study of hypoxia influence on CSC phenotype in CRC. The aim of this mini-review article is to present a brief overview on this field. Recent articles discoursed about CSC molecular regulation, signalling pathways, methods for the study of the topic, as well as molecules and drugs capacity of inhibiting the interplay of hypoxia-CSC. Finally, the studies demonstrated important results, extensively accessing the topics of cellular and molecular regulation and therapeutic intervention, being morphology an area to be more explored.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cancer stem cells; Colorectal cancer; Hypoxia; Stem cell phenotype

Mesh:

Substances:

Year:  2021        PMID: 34637098     DOI: 10.1007/s11033-021-06809-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  44 in total

Review 1.  Colorectal cancer stem cells: from the crypt to the clinic.

Authors:  Ann Zeuner; Matilde Todaro; Giorgio Stassi; Ruggero De Maria
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

2.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

3.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

Review 4.  Cancer stem cells revisited.

Authors:  Eduard Batlle; Hans Clevers
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 6.  Stem cell fate in cancer growth, progression and therapy resistance.

Authors:  Nikki K Lytle; Alison G Barber; Tannishtha Reya
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

Review 7.  Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.

Authors:  Kiyoung Eun; Seok Won Ham; Hyunggee Kim
Journal:  BMB Rep       Date:  2017-03       Impact factor: 4.778

Review 8.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

Review 9.  Cancer stem cells in progression of colorectal cancer.

Authors:  Yujuan Zhou; Longzheng Xia; Heran Wang; Linda Oyang; Min Su; Qiang Liu; Jingguan Lin; Shiming Tan; Yutong Tian; Qianjin Liao; Deliang Cao
Journal:  Oncotarget       Date:  2017-12-22

Review 10.  Drug resistance and new therapies in colorectal cancer.

Authors:  Kevin Van der Jeught; Han-Chen Xu; Yu-Jing Li; Xiong-Bin Lu; Guang Ji
Journal:  World J Gastroenterol       Date:  2018-09-14       Impact factor: 5.742

View more
  1 in total

1.  Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense.

Authors:  Seema Bhuyan; Bidisha Pal; Lekhika Pathak; Partha Jyoti Saikia; Shirsajit Mitra; Sukanya Gayan; Reza Bayat Mokhtari; Hong Li; Chilakamarti V Ramana; Debabrat Baishya; Bikul Das
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.